187 related articles for article (PubMed ID: 29343949)
1. Clinical observations on the use of new anti-VEGF drug, conbercept, in age-related macular degeneration therapy: a meta-analysis.
Cui C; Lu H
Clin Interv Aging; 2018; 13():51-62. PubMed ID: 29343949
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effectiveness and safety between conbercept and ranibizumab for treatment of neovascular age-related macular degeneration. A retrospective case-controlled non-inferiority multiple center study.
Cui J; Sun D; Lu H; Dai R; Xing L; Dong H; Wang L; Wei D; Jiang B; Jiao Y; Jablonski MM; Charles S; Gu W; Chen H
Eye (Lond); 2018 Feb; 32(2):391-399. PubMed ID: 28937147
[TBL] [Abstract][Full Text] [Related]
3. Conbercept for patients with age-related macular degeneration: a systematic review.
Zhang J; Liang Y; Xie J; Li D; Hu Q; Li X; Zheng W; He R
BMC Ophthalmol; 2018 Jun; 18(1):142. PubMed ID: 29902977
[TBL] [Abstract][Full Text] [Related]
4. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD007419. PubMed ID: 30325017
[TBL] [Abstract][Full Text] [Related]
5. Clinical efficacy of conbercept injection on neovascular age-related macular degeneration under different levels of inflammation.
Zhang X; Zhuang X; Dong J; Fu B; Zhang G; Xu L
Adv Clin Exp Med; 2024 Apr; 33(4):335-342. PubMed ID: 37747440
[TBL] [Abstract][Full Text] [Related]
6. Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis.
Virgili G; Parravano M; Evans JR; Gordon I; Lucenteforte E
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD007419. PubMed ID: 28639415
[TBL] [Abstract][Full Text] [Related]
7. Non-responsiveness and tachyphylaxis to anti-vascular endothelial growth factor treatment in naive patients with exudative age-related macular degeneration.
Zuber-Laskawiec K; Kubicka-Trzaska A; Karska-Basta I; Pociej-Marciak W; Romanowska-Dixon B
J Physiol Pharmacol; 2019 Oct; 70(5):. PubMed ID: 32009630
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study.
Li X; Xu G; Wang Y; Xu X; Liu X; Tang S; Zhang F; Zhang J; Tang L; Wu Q; Luo D; Ke X;
Ophthalmology; 2014 Sep; 121(9):1740-7. PubMed ID: 24793528
[TBL] [Abstract][Full Text] [Related]
9. Conbercept for Treatment of Neovascular Age-related Macular Degeneration: Results of the Randomized Phase 3 PHOENIX Study.
Liu K; Song Y; Xu G; Ye J; Wu Z; Liu X; Dong X; Zhang M; Xing Y; Zhu S; Chen X; Shen Y; Huang H; Yu L; Ke Z; Rosenfeld PJ; Kaiser PK; Ying G; Sun X; Xu X;
Am J Ophthalmol; 2019 Jan; 197():156-167. PubMed ID: 30148987
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Efficacy and Safety between Conbercept and Ranibizumab in Neovascular Age-Related Macular Degeneration: A Meta-Analysis of Randomized Controlled Trials.
Wang X; Yu C; Yang J; Liu Y; Xu Y; Li W
Ophthalmic Res; 2022; 65(2):140-151. PubMed ID: 34583363
[TBL] [Abstract][Full Text] [Related]
11. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
12. [Serum antiretinal antibodies (ARA) in patients with exudative age-related macular degeneration (AMD) treated with transpupillary thermotherapy (TTT) alone and with transpupillary thermotherapy (TTT) combined with injection of triamcinolone acetonide (sTTA) under posterior Tenon's capsule].
Kubicka-Trzaska A; Wilańska J
Klin Oczna; 2011; 113(1-3):28-33. PubMed ID: 21853947
[TBL] [Abstract][Full Text] [Related]
13. Profile of conbercept in the treatment of neovascular age-related macular degeneration.
Lu X; Sun X
Drug Des Devel Ther; 2015; 9():2311-20. PubMed ID: 25960634
[TBL] [Abstract][Full Text] [Related]
14. Conbercept (KH-902) for the treatment of neovascular age-related macular degeneration.
Nguyen TT; Guymer R
Expert Rev Clin Pharmacol; 2015; 8(5):541-8. PubMed ID: 26289225
[TBL] [Abstract][Full Text] [Related]
15. Treatment regimens for administration of anti-vascular endothelial growth factor agents for neovascular age-related macular degeneration.
Li E; Donati S; Lindsley KB; Krzystolik MG; Virgili G
Cochrane Database Syst Rev; 2020 May; 5(5):CD012208. PubMed ID: 32374423
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 12-month therapeutic effect of conbercept and ranibizumab for diabetic macular edema: a real-life clinical practice study.
Xu Y; Rong A; Xu W; Niu Y; Wang Z
BMC Ophthalmol; 2017 Aug; 17(1):158. PubMed ID: 28841827
[TBL] [Abstract][Full Text] [Related]
17. Clinical effectiveness of ranibizumab and conbercept for neovascular age-related macular degeneration: a meta-analysis.
Wang L; Zhang C; Hua R
Drug Des Devel Ther; 2018; 12():3625-3633. PubMed ID: 30464394
[TBL] [Abstract][Full Text] [Related]
18. Anti-vascular endothelial growth factor combined with intravitreal steroids for diabetic macular oedema.
Mehta H; Hennings C; Gillies MC; Nguyen V; Campain A; Fraser-Bell S
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011599. PubMed ID: 29669176
[TBL] [Abstract][Full Text] [Related]
19. A systematic review and meta-analysis to compare the efficacy of conbercept with ranibizumab in patients with macular edema secondary to retinal vein occlusion.
Liu W; Li Y; Cao R; Bai Z; Liu W
Medicine (Baltimore); 2020 May; 99(21):e20222. PubMed ID: 32481293
[TBL] [Abstract][Full Text] [Related]
20. Comparative study on the efficacy of Conbercept and Aflibercept in the treatment of neovascular age-related macular degeneration.
Xie H; Ju H; Lu J; Wang X; Peng H
Sci Rep; 2024 May; 14(1):11997. PubMed ID: 38796619
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
